According to M*, $XT spans big data and analytics, nanotechnology, medicine, networks, energy and environmental systems, robotics, 3-D printing, bioinformatics and financial services.
I've looked into the allocation, and it seems pretty diversified. 200 stocks equally weighted, spanning different sectors (30% healthcare, 30% tech...) and countries (60% US / 40% developed)
Honestly, it seems like an attractive long-term investment, but I'm new to investing and I haven't found any perspectives/insights/analyses on whether it's actually a good idea.
Submitted February 14, 2017 at 11:12PM by TimWestergren http://ift.tt/2li4lRs
